The following parameters were investigated in relation to patient survival: age, sex, tumor sidedness, final lineage of chemotherapy, the presence of type 2 diabetes and/or hypertension, platelet count, and the plasma level of PD-1 or PD-L1. Here, PDCD1 is linked to type 2 diabetes mellitus.